Rabeprazole sodium and cinitapride capsules are a combination therapy used for gastrointestinal disorders where acid reflux co-exists with slow gut movement (dysmotility). They typically come in a fixed-dose strength of 20 mg (enteric-coated) and 3 mg (sustained/extended-release).